GLRA
CLVS
Gerald L. Ray & Associates’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $3.51M | Buy |
+42,630
| New | +$3.51M | 0.44% | 63 |
|
|
2016
Q2 | – | Sell |
-21,560
| Closed | -$414K | – | 307 |
|
|
2016
Q1 | $414K | Sell |
21,560
-700
| -3% | -$13.4K | 0.07% | 202 |
|
|
2015
Q4 | $779K | Sell |
22,260
-9,820
| -31% | -$344K | 0.12% | 148 |
|
|
2015
Q3 | $2.95M | Sell |
32,080
-1,000
| -3% | -$92K | 0.49% | 55 |
|
|
2015
Q2 | $2.91M | Sell |
33,080
-100
| -0.3% | -$8.79K | 0.44% | 60 |
|
|
2015
Q1 | $2.46M | Sell |
33,180
-500
| -1% | -$37.1K | 0.37% | 69 |
|
|
2014
Q4 | $1.89M | Buy |
33,680
+13,500
| +67% | +$756K | 0.29% | 86 |
|
|
2014
Q3 | $915K | Buy |
20,180
+3,970
| +24% | +$180K | 0.15% | 133 |
|
|
2014
Q2 | $671K | Buy |
16,210
+11,210
| +224% | +$464K | 0.11% | 161 |
|
|
2014
Q1 | $346K | Buy |
5,000
+700
| +16% | +$48.4K | 0.06% | 227 |
|
|
2013
Q4 | $259K | Buy |
+4,300
| New | +$259K | 0.05% | 247 |
|